BIOJECT MED TECHNS COM NPV (BJCT)

0.00
0.00 (0.00)
OTC
Prev Close 0.00
Open 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.12
Volume 1.80K
Exchange OTC
Shares Outstanding 18.91B
Div & Yield N.A. (N.A)

Latest News

Bioject's Distributor Meditrend International Receives Australian Device Registration

Bioject's Distributor Meditrend International Receives Australian Device Registration

Products include the BiojectorA® 2000, Vial Adapter and BiojectA® Zetajeta¿¢

Bioject Enters Into Agreement With Fondaco PTE LTD For Distribution Of Full Line Of Needle Free Injection Devices In Asia

Bioject Enters Into Agreement With Fondaco PTE LTD For Distribution Of Full Line Of Needle Free Injection Devices In Asia

Agreement advances Bioject's global market expansion strategy through Fondaco's established medical device marketing and distribution networks in countries including Singapore, Malaysia and Indonesia

Bioject Enters Into Three Distribution Agreements

Bioject Enters Into Three Distribution Agreements

Bioject Medical Technologies Inc. (OTC Pink: BJCT), a developer and manufacturer of needle-free injection therapy systems, today announced that it has entered into three international distribution agreements, two in...

Bioject Reports Unaudited Year-End And Quarterly 2012 Financial Results

Bioject Reports Unaudited Year-End And Quarterly 2012 Financial Results

Bioject Medical Technologies Inc. (OTC Pink:BJCT), a developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended December 31, 2012.

Bioject Reports Unaudited Year-End 2011 And First Quarter 2012 Financial Results

Bioject Reports Unaudited Year-End 2011 And First Quarter 2012 Financial Results

Bioject Medical Technologies Inc. (Pink Sheets:BJCT), an innovative developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended...

Bioject Retains Financial Advisor To Explore Strategic Alternatives

Bioject Retains Financial Advisor To Explore Strategic Alternatives

Bioject Medical Technologies Inc. (OCTBB: BJCT), a leading developer of needle-free drug delivery systems, today announced that it has retained the services of Mr.

Bioject Announces Change In President And Chief Executive Officer

Bioject Medical Technologies Inc. (OCTBB:BJCT), a leading developer of needle-free drug delivery systems, today announced the departure of Mr.

Bioject Reports Third Quarter 2011 Financial Results

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the third quarter ended September 30, 2011.

FDA Communication On Use Of Jet Injectors With Influenza Vaccines

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today announced that the Food and Drug Administration (FDA) has issued a communication on the use of jet ...

Bioject®ZetaJet™ To Be Utilized By Publix For Flu Season Immunizations

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announced today that beginning in September 2011, select Publix Super Markets (Publix) in the Southeast ...

Fred Meyer To Offer Needle-Free Flu Vaccines For First Time

Fred Meyer customers now have a needle-free option to be immunized against the flu this fall.

Bioject Reports Second Quarter 2011 Financial Results

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2011.

Bioject To Report Second Quarter 2011 Financial Results

Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the second quarter ended June 30, ...

Bioject Medical Technologies Inc. Annual Shareholder Meeting Thursday, June 9, 2011

Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will hold its Annual Shareholder Meeting on Thursday, June 9, 2011 at ...

Bioject Reports First Quarter 2011 Financial Results

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the quarter ended March 31, 2011.

Bioject To Report First Quarter 2011 Financial Results

Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the first quarter ended March 31, ...

Bioject Reports Fourth Quarter And Year-End 2010 Financial Results

Bioject Medical Technologies Inc. (OTCBB:BJCT), an innovative developer and manufacturer of needle-free injection therapy systems, today reported financial results for the year and quarter ended December 31, 2010.

Bioject To Report Fourth Quarter And Year-End 2010 Financial Results

Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the fourth quarter and year ended ...

Bioject Announces Collaboration To Provide Needle-Free Pen Injector For Intradermal Delivery Studies

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announces its support for efforts to advance clinical research of intradermal delivery of vaccines in ...

Bioject Reports Third Quarter 2010 Financial Results

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced financial results for the third quarter of 2010.

Bioject To Report Third Quarter 2010 Financial Results

Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the third quarter ended September ...

Biojector®2000 Utilized In A Human Clinical Trial Of DNA-MVA HIV Vaccine

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that its unique Needle-Free Injection Therapy (NFIT) system, the Biojector ® 2000, is...

Bioject Reports Second Quarter 2010 Financial Results

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2010.

Bioject To Report Second Quarter 2010 Financial Results

Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the second quarter ended June 30, ...

Bioject’s Intradermal Needle-Free Delivery System Used In World Health Organization Clinical Trial In Oman With Poliovirus Vaccine

Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, today announced that Bioject’s needle-free injection delivery technology was used to successfully ...

Bioject Medical Technologies Inc. Annual Shareholder Meeting Thursday, June 10, 2010

Bioject Medical Technologies Inc., (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will hold its Annual Shareholder Meeting on Thursday, June 10, 2010 at ...

From Our Partners